We are live on ! Find out more
CORV

Correvio Pharma Corp. Ordinary Shares (Canada)
CORV

Delisted

CORV was delisted on the 26th of May, 2020.

Back to rankings

32 hedge funds and large institutions have $56M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $53.8M → $56M (+$2.22M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

9% less funds holding

Funds holding: 35 → 32 (-3)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

38% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 13

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $296K

Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
8
Reduced
13
Closed
6
Calls
–
Puts
$296K
Net Calls
-$296K
Net Calls Change
-$103K

Top Buyers

Rank Fund Capital Flow
1
DMK
David M. Knott
+$225K
2
JP Morgan Chase
JP Morgan Chase
New York
+$170K
3
Renaissance Technologies
Renaissance Technologies
New York
+$113K
4
Simplex Trading
Simplex Trading
Illinois
+$55.7K
5
VKH
Virtu KCG Holdings
New York
+$46.2K

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$1.18M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$541K
3
SM
Sabby Management
Florida
-$486K
4
CS
Credit Suisse
Switzerland
-$317K
5
CCP
Clough Capital Partners
Massachusetts
-$303K

CORV Hedge Fund Activity: Q1 2017 in Review

32 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q1 2017, worth a combined $56M — up 4.1% from $53.8M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CORV and 4 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 8 added.

The largest buyer was David M. Knott, opening a new position worth an estimated $225K. The largest seller was Stonepine Capital Management, cutting an estimated $1.18M.

  • 32 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q1 2017, down from 35 in Q4 2016.
  • Funds reported $56M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q1 2017, up 4.1% quarter-over-quarter.
  • 4 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q1 2017 and 6 closed out, a net change of -2 holders.
  • The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q1 2017 was David M. Knott, an estimated $225K added.
  • The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q1 2017 was Stonepine Capital Management, an estimated $1.18M sold.

Based on aggregated 13F filings for Q1 2017.